Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CISPLATIN for B-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 479 adverse event reports in the FDA FAERS database where CISPLATIN was used for B-cell lymphoma.

Most Reported Side Effects for CISPLATIN

Side Effect Reports % Deaths Hosp.
Off label use 4,359 9.2% 746 1,415
Disease progression 3,746 7.9% 880 500
Neutropenia 3,095 6.5% 464 920
Febrile neutropenia 3,010 6.3% 580 1,580
Nausea 2,923 6.2% 282 1,470
Drug ineffective 2,608 5.5% 744 607
Thrombocytopenia 2,565 5.4% 410 911
Anaemia 2,530 5.3% 338 1,111
Vomiting 2,326 4.9% 286 1,314
Diarrhoea 2,022 4.3% 376 1,069
Malignant neoplasm progression 2,004 4.2% 726 446
Pyrexia 1,863 3.9% 243 1,263
Myelosuppression 1,849 3.9% 106 843
Acute kidney injury 1,783 3.8% 279 1,162
Fatigue 1,394 2.9% 161 561

Other Indications for CISPLATIN

Diffuse large b-cell lymphoma (2,703) Product used for unknown indication (2,614) Non-small cell lung cancer (1,762) Plasma cell myeloma (1,239) Oesophageal carcinoma (1,094) Lung adenocarcinoma (1,003) Lung neoplasm malignant (988) Osteosarcoma (975) Chemotherapy (958) Cholangiocarcinoma (923)

Other Drugs Used for B-cell lymphoma

RITUXIMAB (7,811) CYCLOPHOSPHAMIDE (4,766) VINCRISTINE (4,346) DOXORUBICIN (3,947) LENALIDOMIDE (3,474) PREDNISONE (2,561) BENDAMUSTINE (1,668) PREDNISOLONE (1,489) ETOPOSIDE (1,268) IDELALISIB (1,240)

Related Pages

CISPLATIN Full Profile All B-cell lymphoma Drugs CISPLATIN Demographics CISPLATIN Timeline